Thyrocare Sells 100% Stake in Nueclear Healthcare for ₹141.4 Cr

Thyrocare Technologies Ltd has executed a Share Purchase Agreement to sell its entire 100% shareholding in its wholly-owned subsidiary, Nueclear Healthcare Limited (NHL), to Trovera Healthcare Private Limited. The transaction, approved by shareholders via special resolution, is valued at approximately ₹1,414,000,000 (₹141.4 Crore). The consideration comprises ₹595,000,000 (₹59.5 Crore) in Compulsorily Convertible Preference Shares (CCPS) of Trovera and ₹819,000,000 (₹81.9 Crore) in cash, subject to working capital adjustments. This divestment marks Thyrocare's exit from its stake in NHL, which will become a wholly-owned subsidiary of Trovera post-completion.